FERRACIN, MANUELA
 Distribuzione geografica
Continente #
AS - Asia 10.263
NA - Nord America 9.496
EU - Europa 7.091
SA - Sud America 664
AF - Africa 508
Continente sconosciuto - Info sul continente non disponibili 61
OC - Oceania 19
Totale 28.102
Nazione #
US - Stati Uniti d'America 9.315
CN - Cina 2.920
VN - Vietnam 2.572
SG - Singapore 2.538
IT - Italia 2.352
GB - Regno Unito 1.206
DE - Germania 825
HK - Hong Kong 681
SE - Svezia 525
BR - Brasile 460
IN - India 440
FR - Francia 425
RU - Federazione Russa 347
KR - Corea 298
NL - Olanda 239
IE - Irlanda 237
FI - Finlandia 191
ZA - Sudafrica 180
JP - Giappone 150
UA - Ucraina 113
CI - Costa d'Avorio 104
EE - Estonia 104
AR - Argentina 100
CA - Canada 100
CH - Svizzera 100
BD - Bangladesh 89
HR - Croazia 87
ID - Indonesia 86
SC - Seychelles 86
PK - Pakistan 84
TG - Togo 64
AT - Austria 63
EU - Europa 61
PH - Filippine 58
JO - Giordania 57
ES - Italia 52
IQ - Iraq 52
MX - Messico 52
TH - Thailandia 50
PL - Polonia 49
BG - Bulgaria 43
TR - Turchia 39
EC - Ecuador 34
TW - Taiwan 31
IR - Iran 26
BE - Belgio 23
GR - Grecia 23
CL - Cile 19
SA - Arabia Saudita 19
AU - Australia 17
UZ - Uzbekistan 14
MA - Marocco 13
RO - Romania 13
CO - Colombia 12
DK - Danimarca 12
NG - Nigeria 12
PE - Perù 12
EG - Egitto 11
LT - Lituania 10
MY - Malesia 10
CZ - Repubblica Ceca 9
VE - Venezuela 9
KE - Kenya 8
LB - Libano 7
PY - Paraguay 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
TN - Tunisia 6
CR - Costa Rica 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
JM - Giamaica 5
RS - Serbia 5
SI - Slovenia 5
AZ - Azerbaigian 4
BY - Bielorussia 4
ET - Etiopia 4
IL - Israele 4
MD - Moldavia 4
NP - Nepal 4
PT - Portogallo 4
AL - Albania 3
BA - Bosnia-Erzegovina 3
HU - Ungheria 3
MN - Mongolia 3
SM - San Marino 3
SV - El Salvador 3
AM - Armenia 2
BB - Barbados 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CG - Congo 2
GA - Gabon 2
GM - Gambi 2
LV - Lettonia 2
MM - Myanmar 2
NO - Norvegia 2
OM - Oman 2
PA - Panama 2
Totale 28.066
Città #
Singapore 1.784
Fairfield 1.095
Ashburn 1.032
Southend 1.005
Bologna 682
Ho Chi Minh City 662
Hong Kong 640
San Jose 604
Hefei 580
Hanoi 527
Houston 504
Woodbridge 471
Seattle 460
Chandler 437
Wilmington 387
Cambridge 375
Ann Arbor 330
Beijing 295
Princeton 295
Seoul 272
Santa Clara 245
Dublin 232
Dong Ket 217
Boardman 208
Lauterbourg 197
Dallas 159
Los Angeles 153
Helsinki 149
Nanjing 138
Milan 130
Berlin 124
Tokyo 119
Westminster 118
New York 108
Abidjan 104
Frankfurt am Main 103
Padova 102
Council Bluffs 100
Rome 89
Da Nang 85
Redondo Beach 75
Haiphong 74
Buffalo 73
Bern 72
Shanghai 70
Jinan 69
Guangzhou 67
Lomé 64
Shenyang 64
Jakarta 62
San Diego 62
Saint Petersburg 59
Amman 57
Bengaluru 57
Johannesburg 57
Tianjin 55
Hebei 50
Changsha 48
Nuremberg 47
Olalla 46
London 45
Redmond 45
São Paulo 44
Sofia 41
Zhengzhou 39
Chicago 38
Nanchang 38
Des Moines 37
Munich 37
Amsterdam 36
Warsaw 35
Hangzhou 34
Vienna 34
Naples 33
Toronto 33
Turin 32
Bremen 31
Florence 31
Reggio Emilia 31
Falls Church 30
Lappeenranta 30
Baghdad 29
Norwalk 29
Falkenstein 28
Orem 27
Parma 27
Phoenix 27
Shenzhen 26
Vicenza 26
Xi'an 26
Jacksonville 25
Bangkok 24
Wuhan 24
Brooklyn 23
Jiaxing 23
Thái Nguyên 23
Biên Hòa 22
Boston 22
Can Tho 22
Ferrara 22
Totale 17.774
Nome #
Vaccine-Based Immunotherapy for Oropharyngeal and Nasopharyngeal Cancers 661
ARID1A in cancer: Friend or foe? 365
The Long Noncoding RNA CCAT2 Induces Chromosomal Instability Through BOP1-AURKB Signaling 343
Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations 321
Non-coding RNAs in disease: from mechanisms to therapeutics 311
CAR+ extracellular vesicles predict ICANS in patients with B cell lymphomas treated with CD19-directed CAR T cells 301
Circulating microRNAs, MIR-939, MIR-595, MIR-519d and MIR-494, identify cirrhotic patients with HCC 282
DNA methylation of shelf, shore and open sea CpG positions distinguish high microsatellite instability from low or stable microsatellite status colon cancer stem cells 278
Exploring the Common Mutational Landscape in Cutaneous Melanoma and Pancreatic Cancer 263
Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primary 257
MicroRNA and Metabolic Profiling of a Primary Ovarian Neuroendocrine Carcinoma Pulmonary-Type Reveals a High Degree of Similarity with Small Cell Lung Cancer 251
MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma 233
Peripheral blood cellular profile at pre-lymphodepletion is associated with {CD}19-targeted {CAR}-T cell-associated neurotoxicity 228
Cancer of unknown primary: Challenges and progress in clinical management 228
BRAF, KIT, and NRAS Mutations of Acral Melanoma in White Patients 227
Basal cell carcinoma: A comprehensive review 226
MiR-30e-3p influences tumor phenotype through MDM2/TP53 axis and predicts sorafenib resistance in hepatocellular carcinoma 226
Genomic stability, anti-inflammatory phenotype, and up-regulation of the RNAseH2 in cells from centenarians 224
Pre-transplant CD69+ extracellular vesicles are negatively correlated with active ATLG serum levels and associate with the onset of GVHD in allogeneic HSCT patients 223
LncRNAs as novel players in hepatocellular carcinoma recurrence 223
Case report: Senescence as mechanism of resistance to Pembrolizumab in a Lymphoma patient who failed CD19-Targeted CAR-T cell therapy 218
Diagnostic and Prognostic Value of microRNAs in Patients with Laryngeal Cancer: A Systematic Review 214
A Systematic Review of Diagnostic and Prognostic Biomarkers for Head and Neck Cancer of Unknown Primary: An Unmet Clinical Need 213
ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1- rearranged NSCLC 211
Association of miR-146a-5p and miR-21-5p with Prognostic Features in Melanomas 210
Circulating microRNA biomarkers in melanoma and non-melanoma skin cancer 209
Serum from Advanced Heart Failure Patients Promotes Angiogenic Sprouting and Affects the Notch Pathway in Human Endothelial Cells 205
Metabolic profile evolution in relapsed/refractory B-cell non-Hodgkin lymphoma patients treated with CD19 chimeric antigen receptor T-cell therapy and implications in clinical outcome 204
Heterotopic auxiliary segment 2–3 liver transplantation with delayed total hepatectomy: New strategies for nonresectable colorectal liver metastases 203
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer 200
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. 200
Cancer site-specific multiple microRNA quantification by droplet digital PCR 199
Impact of sialyltransferase ST6GAL1 overexpression on different colon cancer cell types 199
Electrocardiogram analysis in Anderson-Fabry disease: a valuable tool for progressive phenotypic expression tracking 195
Exosomes from CD99-deprived Ewing sarcoma cells reverse tumor malignancy by inhibiting cell migration and promoting neural differentiation 193
MicroRNA profile in gastrointestinal stromal tumors (GISTs) and correlation with KIT/PDGFRA kinase genotype. 189
Cancer-associated rs6983267 SNP and its accompanying long noncoding RNA CCAT2 induce myeloid malignancies via unique SNP-specific RNA mutations 189
Epigenetic and epitranscriptomic changes in colorectal cancer: diagnostic, prognostic, and treatment implications 188
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer 188
Circulating MicroRNA Quantification Using DNA-binding Dye Chemistry and Droplet Digital PCR 186
Correlations Between Cardiac Magnetic Resonance and Myocardial Histologic Findings in Fabry Disease 185
Genetic Characterization of Cancer of Unknown Primary Using Liquid Biopsy Approaches 184
Circulating miR-184 is a potential predictive biomarker of cardiac damage in Anderson–Fabry disease 184
Absolute quantification of cell-free microRNAs in cancer patients 180
Circulating MicroRNAs in Patients with Psoriasis Treated with Anti-IL-23: A Cohort Study 178
Unraveling the role of microRNA/isomiR network in multiple primary melanoma pathogenesis 178
Combining gemcitabine and MSC delivering soluble TRAIL to target pancreatic adenocarcinoma and its stroma 177
Identification of miRNAs differentially expressed in human epilepsy with or without granule cell pathology 177
Combining anti-miR-155 with chemotherapy for the treatment of lung cancers 175
Quantification of Circulating miRNAs by Droplet Digital PCR: Comparison of EvaGreen- and TaqMan-Based Chemistries. 175
High Expression of the Sda Synthase B4GALNT2 Associates with Good Prognosis and Attenuates Stemness in Colon Cancer 175
Gastroesophageal circulating tumor cell crosstalk with peripheral immune system guides CTC survival and proliferation 174
Estrogen Receptors and Melanoma: A Review 173
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality. 169
Integrating miRNA and gene expression profiling analysis revealed regulatory networks in gastrointestinal stromal tumors 169
The Sda synthase B4GALNT2 reduces malignancy and stemness in colon cancer cell lines independently of sialyl lewis X inhibition 168
KRAS and ERBB-family genetic alterations affect response to PD-1 inhibitors in metastatic nonsquamous NSCLC 167
Oncogenic role of miR-483-3p at the IGF2/483 locus. 164
Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia 164
Cellular and Kaposi's sarcoma-associated herpes virus microRNAs in sepsis and surgical trauma. 164
Small extracellular vesicles deliver miR-21 and miR-217 as pro-senescence effectors to endothelial cells 163
MicroRNA profiling of primary pulmonary enteric adenocarcinoma in members from the same family reveals some similarities to pancreatic adenocarcinoma-a step towards personalized therapy 162
Interplay between small and long non-coding RNAs in cutaneous melanoma: a complex jigsaw puzzle with missing pieces 162
Essential role of MED1 in the transcriptional regulation of ER-dependent oncogenic miRNAs in breast cancer 160
Non-coding RNA dysregulation in skin cancers 157
Newly-discovered neural features expand the pathobiological knowledge of blastic plasmacytoid dendritic cell neoplasm 156
CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer 155
MiR-122/Cyclin G1 Interaction Modulates p53 Activity and Affects Doxorubicin Sensitivity of Human Hepatocarcinoma Cells. 154
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 154
Circulating non-coding RNA as biomarkers in colorectal cancer 153
Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B 152
Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells 151
Involvement of the inconstant bursa of the fifth metatarsophalangeal joint in psoriatic arthritis: A clinical and ultrasonographic study 149
Sickle Cell Trait and SARS-CoV-2-Induced Rhabdomyolysis: A Case Report 149
MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis 148
Non-coding RNAs as predictive biomarkers to current treatment in metastatic colorectal cancer 145
Anti-CD38 antibody therapy: windows of opportunity yielded by the functional characteristics of the target molecule. 144
Defining the Prognostic Role of MicroRNAs in Cutaneous Melanoma 144
Differential cytogenomics and miRNA signature of the Acute Myeloid Leukaemia Kasumi-1 cell line CD34+38- compartment 143
MicroRNA dysregulation in ataxia telangiectasia 142
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 142
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts 142
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia 139
First report of circulating microRNAs in tumour necrosis factor receptor-associated periodic syndrome (TRAPS). 139
Quantification of circulating micrornas by droplet digital PCR 139
MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. 139
Altered miRNA expression in T regulatory cells in course of multiple sclerosis. 139
MicroRNA expression profiling with a droplet digital PCR assay enables molecular diagnosis and prognosis of cancers of unknown primary 139
Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs 137
Predictive Factors for Sentinel Lymph Node Positivity in Melanoma Patients—The Role of Liquid Biopsy, MicroRNA and Gene Expression Profile Panels 136
Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155. 136
Decreased serum levels of the inflammaging marker miR-146a are associated with non-clinical response to tocilizumab in COVID-19 patients 136
Circulating microRNAs and isomiRs as biomarkers for the initial insult and epileptogenesis in four experimental epilepsy models: The EPITARGET study 135
MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias 135
miR-126&126* Restored Expressions Play a Tumor Suppressor Role by Directly Regulating ADAM9 and MMP7 in Melanoma 134
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients. 134
MicroRNA profiles in hippocampal granule cells and plasma of rats with pilocarpine-induced epilepsy - Comparison with human epileptic samples 134
Epigenetic age acceleration in hematopoietic stem cell transplantation 133
Surfaces environmental monitoring of SARS-CoV-2: Loop mediated isothermal amplification (LAMP) and droplet digital PCR (ddPCR) in comparison with standard Reverse-Transcription quantitative polymerase chain reaction (RT-qPCR) techniques 132
Clinical Monoclonal B lymphocytosis versus Rai 0 Chronic Lymphocytic Leukemia: a Comparison of Cellular, Cytogenetic, Molecular, and Clinical Features 132
Totale 18.939
Categoria #
all - tutte 79.603
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.603


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021609 0 0 0 0 0 0 0 0 0 0 75 534
2021/20222.639 242 124 196 190 222 163 96 223 108 193 438 444
2022/20232.518 250 322 122 314 147 174 103 145 430 69 231 211
2023/20241.055 101 144 83 104 76 124 77 71 51 71 75 78
2024/20254.856 155 647 473 298 468 246 614 240 112 334 389 880
2025/202610.961 952 1.599 1.099 871 1.036 544 1.126 414 2.261 724 335 0
Totale 28.747